- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04015544
Markers of Atherosclerosis in Overweight, Postmenopausal Women Following Daily Watermelon Consumption
July 8, 2019 updated by: Appalachian State University
Expression of Systemic Markers of Atherosclerosis in Free-living, Overweight, Postmenopausal Women Following Daily Watermelon Consumption for Six Weeks: A Randomized Controlled Trial
The primary purpose of this study is to determine the effectiveness of six weeks of watermelon puree supplementation, compared to control (no treatment), on blood antioxidant capacity, inflammation markers in the blood, biomarkers of metabolism in the blood, and cardiovascular disease markers in the blood, and biomarkers in the blood related to watermelon ingestion in overweight post-menopausal women.
The secondary purpose is to compare body composition and body mass between the watermelon supplement group and the control group.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
ORIENTATION AND PRE-STUDY TESTING (1-2 hours):
- Come to the Lab in the morning in an overnight fasted state.
- Complete orientation to the study, and provide voluntary consent to join the study.
- Complete a medical health questionnaire to verify medical history and lifestyle habits, and provide a 3-day food record.
- Record symptoms on a questionnaire regarding how subjects have felt for the previous four weeks using a 12-point Likert scale. Symptoms relate to digestive health, hunger, energy, infection, pain, allergies, stress, mental focus, and overall wellbeing.
- All forms reviewed to determine eligibility to participate in this study.
- Subject height, body weight, and percent body fat measured.
- A blood sample taken by a trained phlebotomist; the sample not to exceed 40 mL. Blood tested for markers associated with inflammation and cardiovascular health, and nutritional compounds related to drinking watermelon puree.
- Subjects randomized to the Control or Watermelon group. If assigned to the Watermelon group subjects provided a six-week supply of watermelon puree.
- The morning of the study subjects consume the three bottles of watermelon puree (710 mL total, Watermelon group) each day thereafter for six weeks or maintain normal daily fluid intake (Control group).
- Six weeks after beginning the study subjects return to the Laboratory for the final measurements. Subjects to bring all beverage bottles.
6-WEEK LAB VISIT (1-2 hours):
- Participants come to the Lab in the morning in an overnight fasted state.
- Subject body weight, and percent body fat are measured.
- Subjects record symptoms on a questionnaire regarding how they have felt for the previous six weeks.
- A final blood sample (40 mL) taken by a trained phlebotomist.
BLOOD SAMPLE ANALYSES
- Blood borne cardiovascular disease markers: ADAM metallopeptidase with thrombospondin type 1 motif, 13 (ADAMTS13), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble P-selectin (sP-selectin), growth differentiation factor-15 (GDF-15), and soluble intercellular adhesion molecule-1 (sICAM-1) measured according to the manufacturer's specifications using the MAGPIX instrument and xPONENT analysis software (Luminex, Austin, TX).
- Fasting blood glucose, insulin, vitamin C, and high-sensitivity C-reactive (hs-CRP) protein were measured by LabCorp (Burlington, NC).
- Fasting plasma carotenoid concentrations measured commercially (Craft Technologies Inc., Wilson, NC).
- Fasting plasma amino acid concentration determined by high-performance liquid chromatography.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Boone, North Carolina, United States, 28608
- Appalachian State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female
- 50 to 75 years of age,
- have not menstruated for at least 1 year (menopause),
- have a BMI of ≥25 kg/m2,
- nonsmoker with
- no diagnosed history of chronic diseases including: coronary heart disease, stroke, cancer, type 1 or 2 diabetes mellitus, or rheumatoid arthritis;
- may not regularly consume large quantities of L-citrulline/L-arginine rich foods (red meat, tuna fish, cheese, nuts),
- may not regularly take L-citrulline/L-arginine supplements,
- may not use anti-hypertension medications (including diuretic medications),
- may not use exogenous ovarian hormones, or
- may not use medications known to influence inflammation within the two weeks of the study period (specifically non-steroidal anti-inflammatory drugs; NSAIDS).
Exclusion Criteria:
- Male,
- younger than 50 or older than 75 years of age,
- menstruated within the last year,
- have a BMI of <25 kg/m2, smoker,
- diagnosed history of chronic diseases including: coronary heart disease, stroke, cancer, type 1 or 2 diabetes mellitus, or rheumatoid arthritis;
- regularly consume large quantities of L-citrulline/L-arginine rich foods (red meat, tuna fish, cheese, nuts),
- regularly take L-citrulline/L-arginine supplements,
- use anti-hypertension medications (including diuretic medications),
- use exogenous ovarian hormones, or
- use medications known to influence inflammation within the two weeks of the study period (specifically non-steroidal anti-inflammatory drugs; NSAIDS).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control
No intervention
|
|
EXPERIMENTAL: Watermelon
Watermelon puree 710 mL per day for six weeks
|
Pureed whole (100%) watermelon
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in select plasma cardiovascular disease markers
Time Frame: Pre-study and study completion (6 weeks)
|
Plasma concentrations of ADAMTS13, sVCAM-1, sP-selectin, GDF-15, hs-CRP, and sICAM-1
|
Pre-study and study completion (6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood glucose
Time Frame: Pre-study and study completion (6 weeks)
|
Fasting blood glucose
|
Pre-study and study completion (6 weeks)
|
Blood insulin
Time Frame: Pre-study and study completion (6 weeks)
|
Fasting blood insulin
|
Pre-study and study completion (6 weeks)
|
Blood carotenoids
Time Frame: Pre-study and study completion (6 weeks)
|
Fasting blood carotenoids
|
Pre-study and study completion (6 weeks)
|
Blood amino acids
Time Frame: Pre-study and study completion (6 weeks)
|
Fasting blood amino acids
|
Pre-study and study completion (6 weeks)
|
Body mass
Time Frame: Pre-study and study completion (6 weeks)
|
Body mass (kg)
|
Pre-study and study completion (6 weeks)
|
Body mass index
Time Frame: Pre-study and study completion (6 weeks)
|
Body mass index (kg/m2)
|
Pre-study and study completion (6 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: R. Andrew Shanely, Ph.D., Appalachian State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Collins JK, Wu G, Perkins-Veazie P, Spears K, Claypool PL, Baker RA, Clevidence BA. Watermelon consumption increases plasma arginine concentrations in adults. Nutrition. 2007 Mar;23(3):261-6. doi: 10.1016/j.nut.2007.01.005.
- Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976 Oct;85(4):447-52. doi: 10.7326/0003-4819-85-4-447.
- Lum T, Connolly M, Marx A, Beidler J, Hooshmand S, Kern M, Liu C, Hong MY. Effects of Fresh Watermelon Consumption on the Acute Satiety Response and Cardiometabolic Risk Factors in Overweight and Obese Adults. Nutrients. 2019 Mar 12;11(3):595. doi: 10.3390/nu11030595.
- Edwards AJ, Vinyard BT, Wiley ER, Brown ED, Collins JK, Perkins-Veazie P, Baker RA, Clevidence BA. Consumption of watermelon juice increases plasma concentrations of lycopene and beta-carotene in humans. J Nutr. 2003 Apr;133(4):1043-50. doi: 10.1093/jn/133.4.1043.
- Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal. 2011 Sep 15;15(6):1607-38. doi: 10.1089/ars.2010.3522. Epub 2011 May 11.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2014
Primary Completion (ACTUAL)
July 1, 2014
Study Completion (ACTUAL)
July 1, 2014
Study Registration Dates
First Submitted
July 2, 2019
First Submitted That Met QC Criteria
July 8, 2019
First Posted (ACTUAL)
July 11, 2019
Study Record Updates
Last Update Posted (ACTUAL)
July 11, 2019
Last Update Submitted That Met QC Criteria
July 8, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-0092
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted
Clinical Trials on Watermelon
-
Clinical Nutrition Research Center, Illinois Institute...CompletedHealthy SubjectsUnited States
-
Clinical Nutrition Research Center, Illinois Institute...National Watermelon Promotion BoardRecruitingCardiovascular Diseases | Pre-hypertensionUnited States
-
University of ReadingActive, not recruiting
-
Pennington Biomedical Research CenterCompletedEndothelial DysfunctionUnited States
-
Florida State UniversityCompleted
-
Universidade Federal do Rio de JaneiroCompletedHealthy Young | Older People With Cardiovascular Disease RiskBrazil
-
San Diego State UniversityRecruitingOverweight and ObesityUnited States
-
San Diego State UniversityRecruiting
-
San Diego State UniversityRecruiting
-
University of Alabama, TuscaloosaCompletedInflammation | Arterial Stiffness